Literature DB >> 21861274

Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.

Sangeeta Ray Banerjee1, Mrudula Pullambhatla, Youngjoo Byun, Sridhar Nimmagadda, Catherine A Foss, Gilbert Green, James J Fox, Shawn E Lupold, Ronnie C Mease, Martin G Pomper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21861274      PMCID： PMC3192196          DOI： 10.1002/anie.201102872

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  22 in total

Review 1.  Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label.

Authors:  Joeri Kuil; Aldrik H Velders; Fijs W B van Leeuwen
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

2.  Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.

Authors:  John L Joyal; John A Barrett; John C Marquis; Jianqing Chen; Shawn M Hillier; Kevin P Maresca; Marie Boyd; Kenneth Gage; Sridhar Nimmagadda; James F Kronauge; Matthias Friebe; Ludger Dinkelborg; James B Stubbs; Michael G Stabin; Rob Mairs; Martin G Pomper; John W Babich
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

3.  Multimodality imaging of gene transfer with a receptor-based reporter gene.

Authors:  Ron Chen; Jesse J Parry; Walter J Akers; Mikhail Y Berezin; Issam M El Naqa; Samuel Achilefu; W Barry Edwards; Buck E Rogers
Journal:  J Nucl Med       Date:  2010-08-18       Impact factor: 10.057

Review 4.  Non-FDG PET in the practice of oncology.

Authors:  P Caroli; C Nanni; D Rubello; A Alavi; S Fanti
Journal:  Indian J Cancer       Date:  2010 Apr-Jun       Impact factor: 1.224

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.

Authors:  Rafal T Olszewski; Noreen Bukhari; Jia Zhou; Alan P Kozikowski; Jarda T Wroblewski; Susan Shamimi-Noori; Barbara Wroblewska; Tomasz Bzdega; Stefano Vicini; Franca B Barton; Joseph H Neale
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

Review 7.  Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Authors:  Arundhati Ghosh; Warren D W Heston
Journal:  J Cell Biochem       Date:  2004-02-15       Impact factor: 4.429

8.  A low molecular weight PSMA-based fluorescent imaging agent for cancer.

Authors:  Ying Chen; Surajit Dhara; Sangeeta Ray Banerjee; Youngjoo Byun; Mrudula Pullambhatla; Ronnie C Mease; Martin G Pomper
Journal:  Biochem Biophys Res Commun       Date:  2009-10-08       Impact factor: 3.575

9.  Prostate-specific membrane antigen expression in normal and malignant human tissues.

Authors:  D A Silver; I Pellicer; W R Fair; W D Heston; C Cordon-Cardo
Journal:  Clin Cancer Res       Date:  1997-01       Impact factor: 12.531

10.  The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.

Authors:  Norbert Schülke; Olga A Varlamova; Gerald P Donovan; Dangshe Ma; Jason P Gardner; Donna M Morrissey; Robert R Arrigale; Cenchen Zhan; Amy J Chodera; Kenneth G Surowitz; Paul J Maddon; Warren D W Heston; William C Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-28       Impact factor: 11.205
View more
  49 in total

Review 1.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates.

Authors:  Sangeeta Ray Banerjee; Catherine A Foss; Mrudula Pullambhatla; Yuchuan Wang; Senthamizhchelvan Srinivasan; Robert F Hobbs; Kwamena E Baidoo; Martin W Brechbiel; Sridhar Nimmagadda; Ronnie C Mease; George Sgouros; Martin G Pomper
Journal:  J Nucl Med       Date:  2015-02-26       Impact factor: 10.057

Review 3.  Oligonucleotide-based theranostic nanoparticles in cancer therapy.

Authors:  Reza Shahbazi; Bulent Ozpolat; Kezban Ulubayram
Journal:  Nanomedicine (Lond)       Date:  2016-04-22       Impact factor: 5.307

4.  Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.

Authors:  Sangeeta Ray Banerjee; Vivek Kumar; Ala Lisok; Donika Plyku; Zora Nováková; Mary Brummet; Bryan Wharram; Cyril Barinka; Robert Hobbs; Martin G Pomper
Journal:  J Nucl Med       Date:  2018-09-20       Impact factor: 10.057

Review 5.  Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.

Authors:  S Lütje; M Rijpkema; W Helfrich; W J G Oyen; O C Boerman
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

6.  Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation.

Authors:  DeLisa Fairweather; Michael J Coronado; Amanda E Garton; Jennifer L Dziedzic; Adriana Bucek; Leslie T Cooper; Jessica E Brandt; Fatima S Alikhan; Haofan Wang; Christopher J Endres; Judy Choi; Martin G Pomper; Tomás R Guilarte
Journal:  J Cardiovasc Transl Res       Date:  2014-01-09       Impact factor: 4.132

7.  Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.

Authors:  Sangeeta Ray Banerjee; Zhengping Chen; Mrudula Pullambhatla; Ala Lisok; Jian Chen; Ronnie C Mease; Martin G Pomper
Journal:  Bioconjug Chem       Date:  2016-05-09       Impact factor: 4.774

8.  111In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues.

Authors:  Sangeeta R Banerjee; Catherine A Foss; Allen Horhota; Mrudula Pullambhatla; Kevin McDonnell; Stephen Zale; Martin G Pomper
Journal:  Biomacromolecules       Date:  2016-12-21       Impact factor: 6.988

9.  Characterization of a novel metastatic prostate cancer cell line of LNCaP origin.

Authors:  Mark A Castanares; Ben T Copeland; Wasim H Chowdhury; Minzhi M Liu; Ronald Rodriguez; Martin G Pomper; Shawn E Lupold; Catherine A Foss
Journal:  Prostate       Date:  2015-10-26       Impact factor: 4.104

10.  Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.

Authors:  Ying Chen; Mrudula Pullambhatla; Sangeeta R Banerjee; Youngjoo Byun; Marigo Stathis; Camilo Rojas; Barbara S Slusher; Ronnie C Mease; Martin G Pomper
Journal:  Bioconjug Chem       Date:  2012-12-04       Impact factor: 4.774
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.